GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kamada Ltd (NAS:KMDA) » Definitions » Ending Cash Position

KMDA (Kamada) Ending Cash Position : $78.4 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Kamada Ending Cash Position?

Kamada's Ending Cash Position for the quarter that ended in Dec. 2024 was $78.4 Mil.

Kamada's quarterly Ending Cash Position increased from Jun. 2024 ($56.5 Mil) to Sep. 2024 ($72.0 Mil) and increased from Sep. 2024 ($72.0 Mil) to Dec. 2024 ($78.4 Mil).

Kamada's annual Ending Cash Position increased from Dec. 2022 ($34.3 Mil) to Dec. 2023 ($55.6 Mil) and increased from Dec. 2023 ($55.6 Mil) to Dec. 2024 ($78.4 Mil).

Kamada Ending Cash Position Historical Data

The historical data trend for Kamada's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kamada Ending Cash Position Chart

Kamada Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.20 18.59 34.26 55.64 78.44

Kamada Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.64 48.19 56.55 72.00 78.44

Kamada Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Kamada's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=55.641+22.794
=78.4

Kamada's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=72.001+6.434
=78.4

Kamada Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Kamada's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kamada Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kamada Ltd (NAS:KMDA) » Definitions » Ending Cash Position
Comparable Companies
XTAE:REKA XTAE:NXTG XTAE:TKUN XTAE:BLWV-M XTAE:CNTC ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506 BOM:500087 TSE:4507 SZSE:000538 UTHR
Traded in Other Exchanges
KMDA:Israel
Address
2 Holzman Street, P.O. Box 4081, Science Park, Rehovot, ISR, 7670402
Website
https://www.kamada.com
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.